Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,764,644 | 843,000 | 477,010 | 936,448 | 2,173,077 |
| Marketable Securities | 38,500 | 29,000 | 18,300 | 5,300 | 5,100 |
| Receivables | 23,580 | 22,227 | 22,405 | 37,913 | 35,228 |
| Other current assets | 752,390 | 665,492 | 756,478 | 748,944 | 740,134 |
| TOTAL | $2,579,114 | $1,559,719 | $1,274,193 | $1,728,605 | $2,953,539 |
| Non-Current Assets | |||||
| PPE Net | 13,889,890 | 13,465,410 | 14,088,660 | 13,230,470 | 13,267,730 |
| Investments And Advances | 1,160,016 | 1,101,272 | 1,012,481 | 876,233 | 870,801 |
| Other Non-Current Assets | 27,554 | 4,488 | 6,519 | 20,217 | 29,409 |
| TOTAL | $15,077,460 | $14,571,170 | $15,107,660 | $14,126,920 | $14,167,940 |
| Total Assets | $17,656,580 | $16,130,890 | $16,381,850 | $15,855,520 | $17,121,480 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 999,370 |
| Accounts payable and accrued liabilities | 121,956 | 102,960 | 98,320 | 115,338 | 118,690 |
| Accrued Expenses | 56,252 | 12,595 | 51,682 | 12,595 | 54,162 |
| Other current liabilities | 97,493 | 9,019 | 11,375 | N/A | N/A |
| TOTAL | $275,701 | $124,574 | $161,377 | $127,933 | $1,172,222 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,602,019 | 6,139,376 | 6,135,285 | 6,131,194 | 6,127,074 |
| Other Non-Current Liabilities | -65,332 | 12,271 | -222,346 | -38,663 | -115,211 |
| TOTAL | $7,629,060 | $6,142,596 | $6,136,185 | $6,142,494 | $6,135,574 |
| Total Liabilities | $7,904,761 | $6,267,170 | $6,297,562 | $6,270,427 | $7,307,796 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 593,459 | 597,437 | 597,435 | 597,432 | 601,823 |
| Common Shares | 108 | 108 | 108 | 108 | 109 |
| Retained earnings | 2,378,251 | 2,427,448 | 2,517,583 | 2,134,680 | 2,252,945 |
| Other shareholders' equity | 3,275,905 | 3,364,311 | 3,558,164 | 3,446,551 | 3,532,390 |
| TOTAL | $9,751,818 | $9,863,716 | $10,084,290 | $9,585,097 | $9,813,686 |
| Total Liabilities And Equity | $17,656,579 | $16,130,886 | $16,381,852 | $15,855,524 | $17,121,482 |